Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ketorolac tromethamine
Drug ID BADD_D01233
Description Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.[L6358][L6508][L11055][L3674][L11070] It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.[L6520] Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.[L6511]
Indications and Usage For the short-term (~5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
Marketing Status Prescription; Discontinued
ATC Code M01AB15; S01BC05
DrugBank ID DB00465
KEGG ID D00813
MeSH ID D020911
PubChem ID 84003
TTD Drug ID Not Available
NDC Product Code 70518-2927; 0023-2181; 25021-700; 71205-582; 35356-696; 72611-719; 0404-9952; 60687-104; 0409-3796; 60505-1003; 0023-9277; 0338-0076; 71872-7212; 63278-1056; 68083-132; 51662-1488; 35573-450; 50090-2746; 0409-3795; 0404-9884; 50090-4635; 50090-5428; 71205-594; 63323-162; 70518-3308; 45865-613; 71872-7118; 70860-701; 70529-119; 0487-6232; 0404-9883; 50090-4583; 51655-170; 69344-144; 55154-0120; 63323-161; 71872-7234; 72266-119; 68788-8149; 0338-0072; 71872-7132; 61919-138; 66267-418; 63629-2488; 71872-7131; 65862-775; 55150-340; 50090-5013; 70529-121; 70529-120; 80425-0139; 60760-314; 12711-5990; 71872-7213; 62991-2818; 68083-103; 25021-701; 55154-1555; 66993-193; 50090-2762; 68083-134; 76420-250; 72189-335; 71872-7119; 0395-8216; 71872-7022; 43235-0001; 55289-328; 42571-137; 0641-6043; 68071-1787; 55154-9366; 52584-725; 64679-758; 0093-0314; 0641-6041; 55154-9368; 72611-725; 71205-116; 71335-1904; 17478-207; 55154-6960; 69543-388; 71872-7185; 70860-700; 68071-2576; 53069-0620; 14501-0010; 67296-1412; 0641-6042; 76045-107; 0338-0069; 50090-3397; 72189-054; 55154-1556; 68083-104; 72611-722; 68071-2443; 64679-757; 47335-221; 63187-628; 72266-118; 51662-1295; 0409-3793; 55150-341; 50090-3364; 70518-0048; 66267-832; 71872-7188; 51927-0111; 71335-1803; 76045-209; 53002-6990; 63187-128; 51552-1371; 53002-7780; 76420-032; 51927-3443; 76045-104; 70518-2610; 60758-773; 49452-3926; 66577-045; 55154-9398; 63629-2974; 49711-0103; 42291-358; 50090-5609; 0023-3507; 68071-4811; 61314-126; 50090-0601; 55150-339; 66022-0117; 70529-122; 43063-904; 65044-7424; 55111-014; 49452-3919; 76420-252; 71205-296; 68788-7517; 51662-1292; 68071-2400; 47335-219; 47335-220; 38779-2249; 52584-722; 70518-3369; 0378-1134; 66577-016; 68083-133; 68071-2569; 17478-209; 50090-3550; 52584-719; 63187-777; 76045-105; 76420-184; 65862-770; 17478-208; 68071-2252
Synonyms Ketorolac Tromethamine | Acular | Toradol
Chemical Information
Molecular Formula C19H24N2O6
CAS Registry Number 74103-07-4
SMILES C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tubulointerstitial nephritis20.05.02.002--Not Available
Hypoacusis04.02.01.006--
Post procedural haemorrhage24.07.01.014; 12.02.05.004--
Wound haemorrhage24.07.01.029; 12.01.08.017--Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.015--Not Available
Conjunctival hyperaemia06.04.01.004--Not Available
Eye oedema06.08.03.013--Not Available
Lymphatic disorder01.09.01.003--Not Available
Foetor hepaticus09.01.05.006; 07.01.06.026--Not Available
Protein urine present13.13.02.006--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Corneal thinning06.06.03.009--Not Available
Skin burning sensation23.03.03.021; 17.02.06.009--Not Available
Haemorrhage24.07.01.002--Not Available
Weight abnormal13.15.01.016--Not Available
Cystoid macular oedema12.02.02.005; 06.04.06.010--Not Available
Vasodilation procedure25.03.01.001--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Angiopathy24.03.02.007--Not Available
Epidermal necrosis23.03.03.035--Not Available
Urine output increased13.13.03.002--Not Available
Hepatic enzyme increased13.03.01.019--Not Available
Breast disorder21.05.04.004--Not Available
Cardiac disorder02.01.01.003--Not Available
Connective tissue disorder15.06.01.006--Not Available
Malnutrition14.03.02.004--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Gastrointestinal ulcer07.04.04.002--Not Available
The 9th Page    First    Pre   9 10    Next   Last    Total 10 Pages